SCHEMBL14346062

SCHEMBL14346062

CC(C)(C)c1ccc2cc3c(C(N)=O)n[nH]c3cc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 1/20 0.47
▸ IKBKB O14920 2/20 0.44
▸ PRKAG1 P54619 5/20 0.43
▸ PRKAA1 Q13131 5/20 0.43
▸ PRKAB1 Q9Y478 5/20 0.43
▸ PRKAB2 O43741 4/20 0.43
▸ PRKAA2 P54646 4/20 0.43
▸ PRKAG3 Q9UGI9 4/20 0.43
▸ PRKAG2 Q9UGJ0 4/20 0.43
▸ JAK2 O60674 2/20 0.43
▸ JAK1 P23458 1/20 0.43
▸ TYK2 P29597 1/20 0.43
▸ JAK3 P52333 1/20 0.43
▸ GSK3B P49841 1/20 0.40
▸ MAP2K4 P45985 1/20 0.38
▸ SCN10A Q9Y5Y9 3/20 0.38
▸ MITF O75030 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13552125 0.85 JAK2 (0.50) LRRK2IKBKBPRKAG1PRKAA1PRKAB1
SCHEMBL14346059 0.83 MITF (0.43) PRKAA1JAK2TYK2JAK3GSK3B
SCHEMBL14385066 0.82 MAP2K4 (0.49) LRRK2IKBKBPRKAG1PRKAA1PRKAB1
SCHEMBL11911445 0.80 JAK2 (0.55) LRRK2IKBKBPRKAG1PRKAA1PRKAB1
SCHEMBL14368882 0.79 JAK2 (0.51) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
SCHEMBL1142184 0.74 JAK2 (0.54) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
Hydrochloric Acid SCHEMBL1142099 0.73 JAK2 (0.53) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
SCHEMBL2054572 0.72 PRKAG1 (0.55) LRRK2PRKAG1PRKAA1PRKAB1PRKAB2
SCHEMBL23029783 0.72 PRKAG1 (0.54) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
SCHEMBL30587498 0.71 MAP2K4 (0.65) IKBKBJAK3GSK3BMAP2K4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293499-A1 Intracellular Kinase Inhibitors MANNKIND CORPORATION (US) 2007-12-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293499-A1 Intracellular Kinase Inhibitors PI4KB, BTK, LTK LRRK2 917/4885IKBKB 107/4885PRKAG1 123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback